Teladoc Health (NYSE:TDOC) Hits New 52-Week Low at $12.36

Shares of Teladoc Health, Inc. (NYSE:TDOC) reached a new 52-week low on Wednesday . The company traded as low as $12.36 and last traded at $12.38, with a volume of 954796 shares traded. The stock had previously closed at $12.88.

Analyst Ratings Changes

Several analysts recently weighed in on TDOC shares. DA Davidson cut their price target on Teladoc Health from $22.00 to $18.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 21st. TD Cowen decreased their target price on Teladoc Health from $16.00 to $15.00 and set a “hold” rating on the stock in a research report on Friday, April 26th. Stifel Nicolaus lowered their price objective on Teladoc Health from $21.00 to $16.00 and set a “hold” rating for the company in a research note on Friday, April 26th. Oppenheimer dropped their target price on Teladoc Health from $26.00 to $21.00 and set an “outperform” rating for the company in a research report on Friday, April 26th. Finally, Royal Bank of Canada dropped their target price on shares of Teladoc Health from $25.00 to $18.00 and set an “outperform” rating on the stock in a report on Friday, April 26th. Twelve analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $18.73.

Teladoc Health Price Performance

The business has a 50-day moving average price of $14.32 and a 200 day moving average price of $17.43. The company has a current ratio of 3.82, a quick ratio of 3.74 and a debt-to-equity ratio of 0.67. The company has a market cap of $2.08 billion, a price-to-earnings ratio of -9.14 and a beta of 0.97.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02). The firm had revenue of $646.13 million for the quarter, compared to analysts’ expectations of $637.31 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same period last year, the business earned ($0.37) earnings per share. As a group, research analysts expect that Teladoc Health, Inc. will post -1.04 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Teladoc Health news, EVP Andrew Turitz sold 6,190 shares of the company’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $89,878.80. Following the transaction, the executive vice president now owns 39,429 shares of the company’s stock, valued at approximately $572,509.08. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, EVP Andrew Turitz sold 6,190 shares of the firm’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $89,878.80. Following the sale, the executive vice president now owns 39,429 shares of the company’s stock, valued at $572,509.08. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CMO Stephany Verstraete sold 7,945 shares of the firm’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $115,361.40. Following the sale, the chief marketing officer now owns 56,486 shares in the company, valued at $820,176.72. The disclosure for this sale can be found here. Insiders sold 138,368 shares of company stock worth $1,989,227 in the last quarter. 0.95% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Teladoc Health

Several hedge funds have recently bought and sold shares of the company. Hexagon Capital Partners LLC increased its stake in Teladoc Health by 204.4% during the 4th quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock worth $34,000 after acquiring an additional 1,065 shares during the period. Lecap Asset Management Ltd. bought a new position in Teladoc Health in the fourth quarter valued at approximately $1,530,000. Sowell Financial Services LLC raised its position in Teladoc Health by 40.8% during the fourth quarter. Sowell Financial Services LLC now owns 18,907 shares of the health services provider’s stock valued at $407,000 after purchasing an additional 5,475 shares in the last quarter. Deutsche Bank AG grew its position in Teladoc Health by 12.4% in the third quarter. Deutsche Bank AG now owns 301,147 shares of the health services provider’s stock valued at $5,598,000 after acquiring an additional 33,287 shares during the last quarter. Finally, Vestmark Advisory Solutions Inc. bought a new position in shares of Teladoc Health in the fourth quarter worth about $6,891,000. 76.82% of the stock is currently owned by institutional investors and hedge funds.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.